News | March 16, 2024
Evonik makes five generations healthier with EUDRAGIT coatings for targeted drug delivery
More than 10,000 scientific publications containing EUDRAGIT
More than 10,000 scientific publications containing EUDRAGIT
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
It is the first autotaxin inhibitor to be investigated in cancer patients
These approvals mark significant progress for Venus Remedies in expanding its market presence
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Acquisition of exclusive commercialization rights for European markets
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Subscribe To Our Newsletter & Stay Updated
